188 related articles for article (PubMed ID: 30728292)
1. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.
Shin S; Buel GR; Nagiec MJ; Han MJ; Roux PP; Blenis J; Yoon SO
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2967-2976. PubMed ID: 30728292
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
[TBL] [Abstract][Full Text] [Related]
3. A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer.
Sankpal NV; Fleming TP; Sharma PK; Wiedner HJ; Gillanders WE
Oncogene; 2017 Jun; 36(26):3706-3717. PubMed ID: 28192403
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
5. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
6. MiR-27a promotes EMT in ovarian cancer through active Wnt/đťś·-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
7. RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation.
Karthikeyan S; Casey PJ; Wang M
Breast Cancer Res; 2022 Oct; 24(1):72. PubMed ID: 36307864
[TBL] [Abstract][Full Text] [Related]
8. ERK signalling modulates epigenome to drive epithelial to mesenchymal transition.
Navandar M; Garding A; Sahu SK; Pataskar A; Schick S; Tiwari VK
Oncotarget; 2017 Apr; 8(17):29269-29281. PubMed ID: 28418928
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated anti-sense ERK2 gene therapy inhibits tubular epithelial-mesenchymal transition and ameliorates renal allograft fibrosis.
Ding Z; Chen Z; Chen X; Cai M; Guo H; Chen X; Gong N
Transpl Immunol; 2011 Jul; 25(1):34-41. PubMed ID: 21530658
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
Tsai CC; Chou YT; Fu HW
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.
Chen C; Han G; Li Y; Yue Z; Wang L; Liu J
J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
13. Knockdown on aPKC-Îą inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
[TBL] [Abstract][Full Text] [Related]
14. FOXO1 is crucial in glioblastoma cell tumorigenesis and regulates the expression of SIRT1 to suppress senescence in the brain.
Yan H; Wu A
Mol Med Rep; 2018 Feb; 17(2):2535-2542. PubMed ID: 29207098
[TBL] [Abstract][Full Text] [Related]
15. ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer.
Chandra Mangalhara K; Manvati S; Saini SK; Ponnusamy K; Agarwal G; Abraham SK; Bamezai RNK
Cancer Lett; 2017 Apr; 391():59-73. PubMed ID: 28109909
[TBL] [Abstract][Full Text] [Related]
16. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling.
Liu L; Wu B; Cai H; Li D; Ma Y; Zhu X; Lv Z; Fan Y; Zhang X
Exp Cell Res; 2018 Jan; 362(2):532-540. PubMed ID: 29277502
[TBL] [Abstract][Full Text] [Related]
17. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions.
Lv Z; Hu M; Zhen J; Lin J; Wang Q; Wang R
Int J Biochem Cell Biol; 2013 Feb; 45(2):255-64. PubMed ID: 23153508
[TBL] [Abstract][Full Text] [Related]
18. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
19. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
[TBL] [Abstract][Full Text] [Related]
20. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
